After two decades in medical technology, I have watched robotic systems evolve from experimental tools into standard equipment in hundreds of operating rooms. The current generation of AI-assisted surgical platforms is not science fiction. It is here, and it is changing how we plan, execute, and follow up on procedures. But as with any powerful tool, understanding what is under the hood is essential for safe and effective use.

Let me start with the practical core. AI in surgery today focuses on three areas: preoperative planning, intraoperative guidance, and postoperative assessment. In planning, the AI analyzes CT or MRI scans to create 3D models of the patient’s anatomy. It can highlight critical structures like vessels or nerves that might be difficult to see with the naked eye. During the procedure, the system provides real-time overlays, showing where the instrument tip is relative to those structures. Some platforms even offer haptic feedback, vibrating the controller when you approach a no-go zone. After surgery, the AI can review video footage to measure tissue handling, instrument movement efficiency, and even predict potential complications based on subtle changes in the surgical field.

When comparing options, you will encounter two main categories. First are the large, multi-arm robotic systems like the da Vinci Xi or the newer Hugo RAS. These are full surgical platforms with multiple arms, a camera, and a console. They are ideal for complex minimally invasive procedures in urology, gynecology, and general surgery. The second category is smaller, modular systems like the Medtronic Hugo or the CMR Versius. These offer more flexibility in OR setup and are often less expensive. A third emerging group is handheld smart instruments, such as the iKnife or the Aquabeam system, which use AI to analyze tissue in real time during resection. The key difference is that full robotic systems provide a complete immersive experience, while modular and handheld tools integrate into your existing workflow.

What should you look for when evaluating an AI-assisted surgery system? First, verify the training data. The AI is only as good as the cases it has learned from. Ask the manufacturer how many procedures were used to train the model and whether it includes diverse patient populations. Second, check the latency. In surgery, milliseconds matter. A system that takes more than 100 milliseconds to process and display an overlay can introduce dangerous lag. Third, consider the user interface. You do not want to be fighting with a complex menu while holding a scalpel. The best systems use simple gestures or voice commands. Fourth, look at the upgrade path. AI models improve over time. Ensure your system can receive software updates without requiring a hardware overhaul. Finally, test the system yourself. Most manufacturers offer simulation modules. Spend at least two hours on the simulator before making a decision.

One practical tip I always share with colleagues: start with a simple procedure. Do not jump into a complex cancer resection on your first AI-assisted case. Begin with a cholecystectomy or a hernia repair. This allows you to learn the system’s behavior, understand the overlay accuracy, and build confidence with the haptic feedback. Also, record your first few cases. Reviewing the video with the AI’s analytics can reveal patterns you might miss in the moment.

My recommendation is straightforward. If your hospital performs more than 50 minimally invasive procedures per month, investing in a full robotic system with AI guidance is likely worth it. For smaller volumes or for specific procedures like prostatectomy or partial nephrectomy, a modular system or a handheld smart instrument can deliver excellent results at a lower cost. Do not be seduced by flashy marketing. Focus on the data, the training, and the real-world outcomes. AI-assisted surgery is a partnership. The machine handles the data and the precision. You bring the judgment and the experience. Together, you can achieve results that neither could alone.